Reduced Port Laparoscopic Gastrectomy for Gastric Cancer

Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy

Trial Details

NCT ID
NCT04295473
Phase
NA
Sponsor
Nanchong Central Hospital
Status
RECRUITING
Cancer Type
Gastric Cancer
Locations (sample)
  • Nanchong, Sichuan, China

Key Eligibility Criteria

  • Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.
  • Eastern Cooperative Oncology Group performance status of 0 or 1.
  • Adequate organ function.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →